About NanoPass

NanoPass Technologies Ltd. is a pioneer in the development and commercialization of nearly painless intradermal delivery solutions for vaccines and drugs. Its flagship product, the 0.6mm MicronJet microneedle, is the first and only true (<1mm) microneedle to receive FDA clearance as an intradermal delivery device for substances approved for delivery below the surface of the skin and is also CE certified.

NanoPass is ISO 13485 certified.

Patented Technology

Robust design

NanoPass’s MicronJet^TM microneedles are based on MEMS (Micro Electro Mechanical Systems) technology and are made of pure silicon crystal

An easy-to-use, consistent and efficient intradermal solution
for nearly painless delivery of drugs and vaccines*

Extensive clinical experience

Wide range of clinical trials with a variety of vaccines and drugs
One of the largest intradermal vaccination database in industry

Ready to commercialize

Regulatory approval in key markets

About NanoPass

Patented Technology

Robust design

It’s all about the size

Applications

Regulatory approvals

An easy-to-use, consistent and efficient intradermal solution for nearly painless delivery of drugs and vaccines*

Extensive clinical experience

Wide range of clinical trials with a variety of vaccines and drugs One of the largest intradermal vaccination database in industry

Ready to commercialize

Regulatory approval in key markets

About NanoPass

Patented Technology

Robust design

It’s all about the size

Applications

Regulatory approvals

An easy-to-use, consistent and efficient intradermal solution
for nearly painless delivery of drugs and vaccines*

Wide range of clinical trials with a variety of vaccines and drugs
One of the largest intradermal vaccination database in industry